ACPL
ACPL is an India-based regulatory affairs consultancy guiding pharmaceutical, medical device, food, cosmetics, and agrochemical companies through CDSCO, FSSAI, BIS, and 15+ Indian regulatory bodies, with dedicated India-entry support for international manufacturers.
- Company typePrivate
- Founded2000
- HeadquartersNoida, India
- Headcount101–250
- GTM typeB2B
- OfferingServices
What ACPL does
ACPL (Accredited Consultants Private Limited) is an India-based regulatory affairs consultancy founded in 2000 and headquartered in Noida, Uttar Pradesh. The firm guides pharmaceutical, medical device, food, cosmetics, agrochemical, and consumer-products companies through India's regulatory landscape, spanning 15+ authorities including CDSCO, FSSAI, BIS, DGFT, WPC, CIB&RC, EPR, Legal Metrology, and PCPNDT. Its core offerings fall into three buckets: regulatory registration and licensing (drug, device, food, cosmetics, BIS, DGFT, WPC, EPR), specialized vigilance services (pharmacovigilance, cosmetovigilance, materiovigilance, food safety vigilance), and clinical development support (clinical trials, field safety trials). ACPL also packages an India Entry Strategy service for international manufacturers seeking a single authorized agent.
The company operates a quote-based, project-priced professional services model with multi-year contract cadences; fees vary by product category, regulatory pathway complexity, and engagement scope and are not publicly disclosed. ACPL goes to market through direct enterprise sales backed by an SEO-optimized website and regulatory-update blog content. It claims 1,150+ clients, 2,700+ completed projects, and 500+ CDSCO product approvals across drugs, medical devices, cosmetics, and diagnostics. Named enterprise logos include Johnson & Johnson, Eli Lilly, BD (Becton Dickinson), Reckitt Benckiser, Mitsubishi, and Nykaa. The team includes 18+ senior regulatory professionals, and the firm is ISO 9001:2015 certified and recognized as a Top 10 Regulatory Consultant in Asia (2023) by Asia Business Outlook Magazine.
ACPL serves as the flagship entity of the ACPL Group, which has built six wholly-owned subsidiaries — Elete Biotech, PharmXL, Accredited Logistics, MedTech Devices, TopFlow, and Pharma Regulatory Institute — extending the parent's footprint into adjacent biotech, pharmaceutical services, logistics, medical device, workflow optimization, and regulatory education verticals. Geographic delivery is pan-India with international client engagement via Indian Authorized Agent representation; revenue, ownership, and detailed headcount figures are not publicly disclosed.
ACPL firmographics
Firmographics- Name
- ACPL
- Legal name
- Accredited Consultants Private Limited
- Website
- https://acplgroupindia.co.in
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- ACPL is an India-based regulatory affairs consultancy guiding pharmaceutical, medical device, food, cosmetics, and agrochemical companies through CDSCO, FSSAI, BIS, and 15+ Indian regulatory bodies, with dedicated India-entry support for international manufacturers.
- Ownership category
- akta.pro rank
ACPL industry classification
Industry- Product category
- Regulatory Affairs Consulting
- akta.pro primary industry
- Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA)
- akta.pro secondary industries
- Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH), Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA) (HLAGAKAJ), Regulatory Affairs & Submissions FSP (HLAGAOAD)
Keywords
Where ACPL is headquartered
LocationHeadquarters
- HQ city
- Noida
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
ACPL business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Regulatory Consulting Services: ACPL generates revenue through professional consulting fees for regulatory affairs services including CDSCO registration, FSSAI licensing, BIS certification, pharmacovigilance, clinical trial support, and market entry strategy services. Revenue is project-based with fees varying by product category, complexity, and scope of engagement.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based consulting |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
ACPL product offering
Product offeringCore offering
ACPL is a regulatory affairs consultancy that provides end-to-end regulatory support for pharmaceutical, medical device, food, cosmetics, and agrochemical companies operating in or entering India. The firm handles CDSCO drug and device registration, FSSAI food licensing, BIS product certification, DGFT import/export approvals, WPC equipment approvals, pharmacovigilance, materiovigilance, cosmetovigilance, clinical trial regulatory support, and India market entry strategy.
Product overview
ACPL is a regulatory affairs consultancy providing expert guidance across India's complex regulatory landscape. The company offers a comprehensive portfolio of regulatory services organized into three main categories: Regulatory Services (covering CDSCO, FSSAI, BIS, DGFT, WPC, EPR, Legal Metrology, and PCPNDT compliance), Specialized Vigilance Services (pharmacovigilance, cosmetovigilance, materiovigilance, and food safety vigilance), and Clinical Development Services (clinical trials and field safety trials). Additional offerings include DSIR Recognition, NPPA Compliance, and Narcotics CBN services. ACPL serves pharmaceutical, medical device, food, cosmetics, and agrochemical industries with a team of 18+ regulatory experts and 25+ years of experience.
Differentiator
Problem solved
Functional benefit
Products and services
- CDSCO Registration Services
Quantifiable outcome
- Successfully completed 500+ CDSCO product approvals across drugs, medical devices, cosmetics, and diagnostics
- +2 more outcomes
Companies that use ACPL
Customer profileNamed customers6 records
Segments7 records
Ideal customer profiles4 records
ACPL technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
ACPL partnerships and signals
Strategic signalScale indicators6 records
Recent moves4 records
Expansion highlights4 records
ACPL competitors and assessment
Company assessmentBroad incumbents
- Parexel International: Global CRO with established regulatory affairs and pharmacovigilance delivery in India. Larger scale and broader portfolio make it a broad incumbent competing for similar enterprise clients.
- ICON plc: Global CRO providing clinical, regulatory, and pharmacovigilance services with India presence. Competes with ACPL on regulatory submissions and post-market safety work.
- IQVIA: Global CRO and life sciences services leader with extensive India regulatory affairs and pharmacovigilance capabilities. Competes for large multinational regulatory mandates in India.
- Sciformix (now Cencora): Scientific and regulatory services provider (now part of Cencora/AmerisourceBergen) with India delivery centers for pharmacovigilance and regulatory operations. Competes for global safety and submission work.
Direct peers
- Indegene: India-based life sciences commercialization and regulatory services firm serving global pharma with medical affairs, regulatory, and safety services. Overlaps with ACPL on pharmacovigilance and regulatory affairs.
- Makro Scientific: Regulatory and scientific consulting firm providing drug registration, pharmacovigilance, and compliance support in India and other regulated markets. Comparable scope and customer profile to ACPL.
- Freyr Solutions: India- and US-headquartered regulatory consulting firm offering regulatory affairs, pharmacovigilance, and medical device services. Directly competes with ACPL across CDSCO, FDA, and global submission work.
- Global Pharma Tek: Regulatory affairs and pharmacovigilance consultancy providing drug, device, and cosmetic registration services across multiple geographies including India. Directly comparable service mix to ACPL.
Emerging players
- Zifo RnD Solutions: India-based scientific informatics and regulatory services provider for pharma and biotech. Adjacent peer with overlapping regulatory and clinical data management offerings.
- Cactus Communications: India-headquartered scientific communications and regulatory writing firm serving global pharma. Overlaps with ACPL on regulatory submissions and medical affairs content.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
ACPL social profiles
Digital presenceACPL compliance and trust
Trust signalCompliance1 record
ACPL financial estimates
Financial estimateRevenue estimate
Valuation estimate
ACPL leadership team
Management profileNumber of profiles
Profiles1 record
ACPL subsidiaries and ownership
Company hierarchySubsidiaries6 records
ACPL funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ACPL M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ACPL
What does ACPL do?
ACPL is a regulatory affairs consultancy that provides end-to-end regulatory support for pharmaceutical, medical device, food, cosmetics, and agrochemical companies operating in or entering India. The firm handles CDSCO drug and device registration, FSSAI food licensing, BIS product certification, DGFT import/export approvals, WPC equipment approvals, pharmacovigilance, materiovigilance, cosmetovigilance, clinical trial regulatory support, and India market entry strategy.
Is ACPL a public or private company?
ACPL is a private company. It is classified as unknown and is currently operating.
When was ACPL founded?
ACPL was founded in 2000. It employs 101 to 250 people.
Where is ACPL based?
ACPL is headquartered in Noida, India, in the Asia region.
How does ACPL make money?
One revenue line is on record: regulatory Consulting Services.
Who are ACPL's main competitors?
Broad incumbents on record are Parexel International, ICON plc, IQVIA and Sciformix (now Cencora). Direct peers are Indegene, Makro Scientific, Freyr Solutions and Global Pharma Tek. Emerging players are Zifo RnD Solutions and Cactus Communications.
Does ACPL have an API?
No public API is recorded for ACPL.
What industry is ACPL in?
ACPL's product category is Regulatory Affairs Consulting. Its primary akta.pro industry code is HLAGAKAA, Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA), with a secondary code of HLAGAAAH, Pharmacovigilance, Risk Management & Medical Affairs CROs.